Discrimination of epileptogenic lesions and perilesional white matter using diffusion tensor magnetic resonance imaging.
Adolescent
Adult
Aged
Anisotropy
Brain Diseases
/ diagnostic imaging
Child
Contrast Media
Diagnosis, Differential
Diffusion Tensor Imaging
/ methods
Epilepsy
/ diagnostic imaging
Female
Ganglioglioma
/ diagnostic imaging
Germany
Humans
Male
Malformations of Cortical Development, Group I
/ diagnostic imaging
Middle Aged
Retrospective Studies
Teratoma
/ diagnostic imaging
White Matter
/ diagnostic imaging
Epilepsy associated lesions
MRI
diffusion tensor imaging
focal cortical dysplasia
long-term epilepsy-associated tumours
Journal
The neuroradiology journal
ISSN: 2385-1996
Titre abrégé: Neuroradiol J
Pays: United States
ID NLM: 101295103
Informations de publication
Date de publication:
Feb 2019
Feb 2019
Historique:
pubmed:
22
11
2018
medline:
5
3
2019
entrez:
22
11
2018
Statut:
ppublish
Résumé
The aim of this study was to evaluate whether ganglioglioma (GGL), dysembryoplastic neuroepithelial tumour (DNET) and FCD (focal cortical dysplasia) are distinguishable through diffusion tensor imaging. Additionally, it was investigated whether the diffusion measures differed in the perilesional (pNAWM) and in the contralateral normal appearing white matter (cNAWM). Six GGLs, eight DNETs and seven FCDs were included in this study. Quantitative diffusion measures, that is, axial, radial and mean diffusivity and fractional anisotropy, were determined in the lesion identified on isotropic T2 or FLAIR-weighted images and in pNAWM and cNAWM, respectively. DNET differed from FCD in mean diffusivity, and GGL from FCD in radial diffusivity. Both types of glioneuronal tumours were different from pNAWM in fractional anisotropy and radial diffusivity. For identifying the tumour edges, threshold values for tumour-free tissue were investigated with receiver operating characteristic analyses: tumour could be separated from pNAWM at a threshold ≤ 0.32 (fractional anisotropy) or ≥ 0.56 (radial diffusivity) *10
Identifiants
pubmed: 30461353
doi: 10.1177/1971400918813991
pmc: PMC6327366
doi:
Substances chimiques
Contrast Media
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
10-16Références
Neurol Res. 2009 Dec;31(10):1102-7
pubmed: 19138470
Radiology. 2009 Apr;251(1):206-15
pubmed: 19190250
Epilepsy Res. 2014 Feb;108(2):336-9
pubmed: 24315018
Neurosurg Rev. 2009 Jul;32(3):275-84; discussion 284-6
pubmed: 19205766
Brain Pathol. 2012 May;22(3):350-79
pubmed: 22497610
Epilepsy Res. 2007 Apr;74(1):33-44
pubmed: 17267178
Eur J Paediatr Neurol. 2013 May;17(3):302-7
pubmed: 23273960
Neurologia. 2016 Sep;31(7):459-65
pubmed: 25660185
Neuroradiology. 2007 Oct;49(10):805-12
pubmed: 17632714
Can J Neurol Sci. 2005 Nov;32(4):477-82
pubmed: 16408578
N Engl J Med. 2017 Oct 26;377(17):1648-1656
pubmed: 29069555
Acta Neuropathol. 1996;91(4):376-84
pubmed: 8928614
Neurobiol Dis. 2006 Apr;22(1):64-75
pubmed: 16309916
Ann Neurol. 2002 Jul;52(1):29-37
pubmed: 12112044
Radiology. 2005 Jun;235(3):985-91
pubmed: 15833979
Brain Connect. 2011;1(6):423-46
pubmed: 22432902
NMR Biomed. 1995 Nov-Dec;8(7-8):333-44
pubmed: 8739270